In the present era of personalized medicine, it has become a top priority to identify and characterize biological factors that serve as early diagnostic tools and predictive markers for the efficacy of therapeutic interventions. Detection and quantification of these markers are particularly important in pathologies such as neurodegenerative disorders, cancer, autoimmune, infectious or inflammatory diseases. From extensive characterization of inflammatory responses potentially triggered post vaccine or cell therapy or gene therapy administration, to the successful detection of trace amounts of a neural scaffolding protein circulating in the blood; companies large and small are turning to soluble biomarkers as a means to measure shifts in pathogenesis and biological processes in response to their candidate products.
As an industry leader in biomarker detection, ABL offers:
Detection & Dosage of Soluble Biomarkers in Clinical Samples
ABL scientists are advancing our clients programs through specialized biomarker services
Examples of Biomarkers Assessed at ABL
Our offering is robust and constantly growing.
Thanks to our broad assortment of assay platforms, you can be assured the biomarker specialists at ABL have solutions for even your most difficult analyte detection challenges.